Perinatal Δ9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats

Neurotoxicology and Teratology

Volumn 21, Issue 3, 1999, Pages 277-283

  Garcia Gil, L ^a   De Miguel, R ^a   Romero, J ^a   Perez, A ^a   Ramos, J A ^a   Fernandez Ruiz J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 Tetrahydrocannabinol; 35S GTP S binding; Cannabinoid receptors; Cannabinoids; GABA; GABA(A) receptors; GABA(B) receptors; Glutamic acid decarboxylase; Perinatal exposure

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; CANNABINOID RECEPTOR; DRONABINOL; GLUTAMATE DECARBOXYLASE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MUSCIMOL; DRUG RECEPTOR; TETRAHYDROCANNABINOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUTAMEN; RAT; STEREOTYPY; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; GESTATIONAL AGE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; WISTAR RAT;

ANIMALS; BACLOFEN; BRAIN; DRUG INTERACTIONS; DRUG SYNERGISM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GESTATIONAL AGE; GLUTAMATE DECARBOXYLASE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MOTOR ACTIVITY; MUSCIMOL; NEURONS; ORGAN SPECIFICITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, GABA-A; RECEPTORS, GABA-B; TETRAHYDROCANNABINOL;

EID: 0032586991     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(98)00058-0     Document Type: Article

References (32)

1. 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56:1995;2177-2184.
2. 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 7:1996;291-308.
3. 9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sci. 63:1998;843-850.
4. Dalterio S., Bartke A. Perinatal exposure to cannabinoids alter male reproductive function in mice. Science. 205:1979;1420-1422.
5. Dalterio S.L. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 12:1980;143-153.
6. Dalterio S.L. Cannabinoid exposure. Effects on development Neurobehav. Toxicol. Teratol. 8:1986;345-352.
7. Fernández-Ruiz J.J., Rodríguez de Fonseca F., Navarro M., Ramos J.A. Maternal cannabinoid exposure and brain development. Changes in the ontogeny of dopaminergic neurons Bartke A., Murphy L.L. Neurobiology and neurophysiology of cannabinoids, biochemistry and physiology of substance abuse, vol. IV. 1992;119-164 CRC Press, Boca Raton, FL.
8. Fernández-Ruiz J.J., Bonnin A., Cebeira M., Ramos J.A. Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure. Palomo T., Archer T. Strategies for studying brain disorders, vol. 1. 1994;Farrand Press, England.
9. Fernández-Ruiz J.J., Romero J., García-Gil L., García-Palomero E., Ramos J.A. Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana. Developmental and adult studies Beninger R.J., Archer T., Palomo T. Dopamine disease states. 1996;CYM Press, Madrid, Spain.
10. 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug. Alcohol Depend. 42:1996;155-166.
11. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain. A quantitative in vitro autoradiographic study J. Neurosci. 11:1991;563-583.
12. Herkenham M., Lynn A.B., de Costa B.R., Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:1991;267-274.
13. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525:1990;78-83.
14. Maneuf Y.P., Crossman A.R., Brotchie J.M. Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2. Synapse. 22:1996;382-385.
15. 9-tetrahydrocannabinol alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicol. Teratol. 9:1987;321-326.
16. 9-tetrahydrocannabinol on developing serotonergic system. Eur. J. Pharmacol. 316:1996;39-42.
17. Murphy L.L., Steger R.W., Bartke A. Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters. Watson R.R. Biochemistry and physiology of substance abuse, vol. 2. 1990;CRC Press, Boca Ratón, FL.
18. Navarro M., Rodríguez de Fonseca F., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47:1994;47-58.
19. Navarro M., de Miguel R., Rodríguez de Fonseca F., Ramos J.A., Fernández-Ruiz J.J. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75:1996;91-98.
20. Nicoletti F., Grandison L., Meek J.L. Effects of repeated administration of estradiol benzoate on tubero-infundibular GABAergic activity in male rats. J. Neurochem. 44:1985;1217-1220.
21. Palkovits M., Brownstein J. Maps and guide to microdissection of the rat brain. 1988;Elsevier Science, New York.
22. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego.
23. 9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology. 27:1988;1256-1270.
24. Rodríguez de Fonseca F., Cebeira M., Fernández-Ruiz J.J., Navarro M., Ramos J.A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
25. Romero J., García-Palomero E., Fernández-Ruiz J.J., Ramos J.A. Involvement of GABA-B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav. Pharmacol. 7:1996;299-302.
26. Romero J., de Miguel R., Ramos J.A., Fernández-Ruiz J.J. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci. 62:1998;351-363.
27. 35S]thio]-triphosphate binding. PNAS (USA). 92:1995;7242-7246.
28. Smith S., Sharp T. Measurement of GABA in rat brain microdialysates using O-phthdialdehyde-sulfite derivatization and high-performance liquid chromatography with electrochemical detection. J. Chromat. B. 652:1994;228-233.
29. 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 680:1995;142-147.
30. 9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats. Brain Res. 807:1998;101-109.
31. Walters D.E., Carr L.A. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25:1986;763-778.
32. Walters D.E., Carr L.A. Perinatal exposure to cannabinoids alters neurochemical development in the rat brain. Pharmacol. Biochem. Behav. 29:1988;213-216.